• Event Type: Earnings Conference Call (Group Meeting) with Institutional Investors/Analysts to discuss operational and financial performance for Q4 and FY ended March 31, 2026.
  • Event Date and Time: Held on Friday, May 29, 2026 (specific time not mentioned in transcript).
  • Purpose: Discussion of the company's fundamental business and financial quarter under review, including quarterly results and strategic updates.
  • Management Participants: Mr. Aankur Patni (Vice Chairman), Mr. Indraneel Dutt (Managing Director & CEO), Mr. Vasant Naik (Group Chief Financial Officer), and Mrs. Nikisha Solanki (Company Secretary).
  • Availability of Materials: The transcript of the call is available on the company's website at www.ionexchangeglobal.com. No mention of presentation decks or recordings being made available.
  • UPSI Statement: The call included a cautionary statement that some statements may be forward-looking and subject to risks, and that the purpose was purely to educate about the company's business. No explicit statement about UPSI was made.
  • Financial Period Discussed: Q4 FY26 (quarter ended March 31, 2026) and full year FY26 (year ended March 31, 2026).
  • Financial Highlights:
  • Q4 FY26 Consolidated: Operating income INR 8,633 million (+3% YoY), EBITDA INR 199 million (margin 2.31%), Net profit INR 243 million (PAT margin 2.81%)
  • FY26 Consolidated: Operating income INR 29,148 million (+7% YoY), EBITDA INR 2,102 million (-29% YoY, margin 7.21%), Net profit INR 1,432 million (PAT margin 4.91%)
  • Segmental Performance (Q4 FY26):
  • Engineering Segment: Revenue INR 5,539 million (flat YoY), EBIT INR 215 million
  • Chemical Segment: Revenue INR 2,297 million (+3% YoY), EBIT INR 334 million
  • Consumer Products: Revenue INR 1,047 million (+34% YoY), Loss INR 46 million (vs loss INR 52 million YoY)
  • Strategic Updates:
  • Engineering order book at INR 26,433 million as of March 31, 2026
  • Technology transfer and manufacturing collaboration with MANN+HUMMEL for ultra-filtration membranes and MBR technology
  • Roha plant fully commissioned and received WQA certification
  • Oman BOOT project (OMR 73.46 million) progressing as per schedule
  • Malawi water treatment project (USD 18.1 million) through joint venture
  • 20-30% capacity utilization target for Roha plant in first full year
  • Challenges Mentioned: West Asia crisis impacting logistics and input costs, legacy project execution delays, UP Jal Jeevan Mission project slow progress (30% scope pending)
  • Forward-looking Statements: Management declined to provide specific FY27 guidance due to dynamic environment but indicated directional improvement in sales and margins. Maintenance CAPEX of INR 30-40 crores envisaged for FY27.

Additional Notes Section

  • Attachments: The regulatory filing indicates an enclosure of the transcript, but no other attachments were mentioned in the provided text.
  • Financial Data Disclosure: Significant financial data was disclosed in the transcript including revenue, EBITDA, net profit, segment performance, and order book figures.
  • Compliance: Filed pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015.